L. E. Bermudez,
“The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report.”,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 19, no. 2, pp. 159-65, 1986.
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S.,
“Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”,
Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.
L. E. Bermudez, Young, L. S., and Enkel, H.,
“Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins.”,
Infection and immunity, vol. 59, no. 5, pp. 1697-702, 1991.
L. E. Bermudez and Inderlied, C. B.,
“Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages.”,
Microbial drug resistance (Larchmont, N.Y.), vol. 3, no. 3, pp. 277-82, 1997.
L. E. Bermudez, Kemper, C. A., and Deresinski, S. C.,
“Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF.”,
Biotherapy (Dordrecht, Netherlands), vol. 8, no. 2, pp. 135-42, 1994.
L. E. Bermudez, Wagner, D., and Sosnowska, D.,
“Mechanisms of Mycobacterium avium pathogenesis.”,
Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B.,
“Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”,
The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.